Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TCT 2017: PCI And CABG Yield Similar QOL Outcomes For Left-Main Disease

Executive Summary

New results from the EXCEL trial, presented at the TCT conference in Denver, found that percutaneous coronary intervention and bypass graft surgery produce similar intermediate-term improvement in the quality-of-life scores of patients with left main coronary artery disease. The results are "testimony to how far PCI has come that it can now stand toe-to-toe with bypass surgery but also give patients a much more rapid recovery," one cardiologist said.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT121701

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel